Aidoc
Clinical AI platform for radiology and enterprise imaging workflows.
Last updated: June 5, 2026
Back to directoryRadiology AI product for detecting and highlighting fractures on trauma X-rays inside clinician-reviewed reading workflows.
Teams that need fracture-detection support for high-volume trauma X-rays while preserving radiologist or clinician interpretation.
Compare within workflow: Medical imaging and radiology · comparison shortlist · source index
Product-specific review. These product-specific signals summarize what the cited sources imply before treating Gleamer BoneView as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Verify BoneView US K222176 and any local CE, Health Canada, or other authorization for the exact module, anatomy, patient age, and clinical site. |
|---|---|
| Privacy | Review imaging-data flow, DICOM metadata, pseudonymized patient data, processor/controller roles, subcontractors, security controls, and retention in the deployment contract. |
| Evidence | Validate performance on local trauma X-rays, pediatric and adult case mix, fracture type, body region, scanner workflow, false positives, false negatives, and report turnaround. |
| Workflow | Best used as a second-reader and prioritization aid inside existing radiology or emergency workflows, with explicit responsibility for accepting, rejecting, and documenting AI marks. |
Gleamer describes BoneView as an AI second-reader for trauma bone X-rays, with workflow integrations, worklist support, and clinical-study references; its regulatory page states that BoneView US is FDA-cleared under K222176 and explains personal-data processing for imaging users.
Not for: Autonomous fracture diagnosis, unsupported body regions or age groups, or applying non-U.S. Gleamer modules as though they share BoneView's U.S. clearance.
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.